Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy-Reference-Cited by-同舟云学术

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy

Published:2012-07-15 Issue:10 Volume:11 Page:895-905
ISSN:1476-1122
Container-title:Nature Materials
language:en
Short-container-title:Nature Mater

Author:

Park Jason,Wrzesinski Stephen H.,Stern Eric,Look Michael,Criscione Jason,Ragheb Ragy,Jay Steven M.,Demento Stacey L.,Agawu Atu,Licona Limon Paula,Ferrandino Anthony F.,Gonzalez David,Habermann Ann,Flavell Richard A.,Fahmy Tarek M.

Publisher

Springer Science and Business Media LLC

Subject

Mechanical Engineering,Mechanics of Materials,Condensed Matter Physics,General Materials Science,General Chemistry

Link

http://www.nature.com/articles/nmat3355.pdf

Reference48 articles.

1. Tawbi, H. A. & Kirkwood, J. M. Management of metastatic melanoma. Semin. Oncol. 34, 532–545 (2007).

2. Atkins, M. B. et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. 17, 2105–2116 (1999).

3. Acquavella, N. et al. Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer. J. Immunother. 31, 569–576 (2008).

4. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Limon, P. The polarization of immune cells in the tumour environment by TGFβ. Nature Rev. Immunol. 10, 554–567 (2010).

5. Gorelik, L. & Flavell, R. A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells. Nature Med. 7, 1118–1122 (2001).

Cited by 457 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment ameliorative and adaptive nanoparticles with photothermal-to-photodynamic switch for cancer phototherapy;Biomaterials;2025-02

2. Co-delivery of PROTAC and siRNA via novel liposomes for the treatment of malignant tumors;Journal of Colloid and Interface Science;2025-01

3. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

4. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects;Frontiers in Immunology;2024-08-23

5. Fabrication of cyborg bacterial cells as living cell–material hybrids using intracellular hydrogelation;Nature Protocols;2024-08-22